About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Circulation: Heart Failure
›
top-articles
Circulation: Heart Failure
5.7
(top 5%)
impact factor
1.9K
(top 10%)
papers
91.6K
(top 5%)
citations
140
(top 5%)
h
-index
5.9
(top 5%)
impact factor
2.3K
all documents
97.4K
doc citations
200
(top 5%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Forecasting the Impact of Heart Failure in the United States
Circulation: Heart Failure
2013
2,206
2
Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction
Circulation: Heart Failure
2010
891
3
Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection Fraction
Circulation: Heart Failure
2011
493
4
Is Worsening Renal Function an Ominous Prognostic Sign in Patients With Acute Heart Failure?
Circulation: Heart Failure
2012
398
5
Exercise Training in Patients With Heart Failure and Preserved Ejection Fraction
Circulation: Heart Failure
2015
386
6
Recent National Trends in Readmission Rates After Heart Failure Hospitalization
Circulation: Heart Failure
2010
373
7
Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial Fibrogenesis
Circulation: Heart Failure
2013
371
8
PDE5 Inhibition With Sildenafil Improves Left Ventricular Diastolic Function, Cardiac Geometry, and Clinical Status in Patients With Stable Systolic Heart Failure
Circulation: Heart Failure
2011
369
9
Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic Cardiomyopathy
Circulation: Heart Failure
2010
364
10
Wireless Pulmonary Artery Pressure Monitoring Guides Management to Reduce Decompensation in Heart Failure With Preserved Ejection Fraction
Circulation: Heart Failure
2014
360
11
Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy
Circulation: Heart Failure
2020
353
12
Left Atrial Remodeling and Function in Advanced Heart Failure With Preserved or Reduced Ejection Fraction
Circulation: Heart Failure
2015
345
13
Effects of the Oral Direct Renin Inhibitor Aliskiren in Patients With Symptomatic Heart Failure
Circulation: Heart Failure
2008
340
14
The Development of Aortic Insufficiency in Left Ventricular Assist Device-Supported Patients
Circulation: Heart Failure
2010
338
15
Exercise Training in Older Patients With Heart Failure and Preserved Ejection Fraction
Circulation: Heart Failure
2010
336
16
Echocardiography-Guided Left Ventricular Lead Placement for Cardiac Resynchronization Therapy
Circulation: Heart Failure
2013
330
17
Outcomes in Advanced Heart Failure Patients With Left Ventricular Assist Devices for Destination Therapy
Circulation: Heart Failure
2012
322
18
High-Sensitivity ST2 for Prediction of Adverse Outcomes in Chronic Heart Failure
Circulation: Heart Failure
2011
319
19
Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction
Circulation: Heart Failure
2015
318
20
Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model
Circulation: Heart Failure
2009
317
21
Venoarterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock and Cardiac Arrest
Circulation: Heart Failure
2018
314
22
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis
Circulation: Heart Failure
2019
312
23
Interleukin-33 Prevents Apoptosis and Improves Survival After Experimental Myocardial Infarction Through ST2 Signaling
Circulation: Heart Failure
2009
306
24
Prevalence of Left Ventricular Diastolic Dysfunction in a General Population
Circulation: Heart Failure
2009
291
25
Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction
Circulation: Heart Failure
2014
288
26
Comparative Safety and Effectiveness of Metformin in Patients With Diabetes Mellitus and Heart Failure
Circulation: Heart Failure
2013
282
27
Classification of Heart Failure in the Atherosclerosis Risk in Communities (ARIC) Study
Circulation: Heart Failure
2012
278
28
Percutaneous Left-Ventricular Support With the Impella-2.5–Assist Device in Acute Cardiogenic Shock
Circulation: Heart Failure
2013
278
29
Predictors of New-Onset Heart Failure
Circulation: Heart Failure
2013
271
30
Clinical Profile and Significance of Delayed Enhancement in Hypertrophic Cardiomyopathy
Circulation: Heart Failure
2008
269
31
Large Animal Models of Heart Failure
Circulation: Heart Failure
2009
267
32
Clinical Outcome 2 Years After Intracoronary Administration of Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction
Circulation: Heart Failure
2010
266
33
Choline Diet and Its Gut Microbe–Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload–Induced Heart Failure
Circulation: Heart Failure
2016
265
34
National Burden of Heart Failure Events in the United States, 2006 to 2014
Circulation: Heart Failure
2018
265
35
Acquired von Willebrand Syndrome in Patients With an Axial Flow Left Ventricular Assist Device
Circulation: Heart Failure
2010
260
36
Risk Related to Pre–Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction
Circulation: Heart Failure
2016
260
37
Loop Diuretics in Acute Decompensated Heart Failure
Circulation: Heart Failure
2009
258
38
Patterns of Disease Progression in Hypertrophic Cardiomyopathy
Circulation: Heart Failure
2012
258
39
Clinical Characteristics of Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction
Circulation: Heart Failure
2011
253
40
Sympathetically Mediated Changes in Capacitance
Circulation: Heart Failure
2011
251
41
Analysis of Metabolic Remodeling in Compensated Left Ventricular Hypertrophy and Heart Failure
Circulation: Heart Failure
2010
248
42
Admission or Changes in Renal Function During Hospitalization for Worsening Heart Failure Predict Postdischarge Survival
Circulation: Heart Failure
2008
246
43
Death in Heart Failure
Circulation: Heart Failure
2008
244
44
Longitudinal Changes in Ejection Fraction in Heart Failure Patients With Preserved and Reduced Ejection Fraction
Circulation: Heart Failure
2012
241
45
Myocardial Titin Hypophosphorylation Importantly Contributes to Heart Failure With Preserved Ejection Fraction in a Rat Metabolic Risk Model
Circulation: Heart Failure
2013
241
46
Cancer Therapy–Related Cardiac Dysfunction and Heart Failure
Circulation: Heart Failure
2016
241
47
Mechanisms of Bleeding and Approach to Patients With Axial-Flow Left Ventricular Assist Devices
Circulation: Heart Failure
2011
239
48
Modest Increase in Peak VO
2
Is Related to Better Clinical Outcomes in Chronic Heart Failure Patients
Circulation: Heart Failure
2012
239
49
Lifetime Analysis of Hospitalizations and Survival of Patients Newly Admitted With Heart Failure
Circulation: Heart Failure
2012
239
50
Body Mass Index and Adverse Cardiovascular Outcomes in Heart Failure Patients With Preserved Ejection Fraction
Circulation: Heart Failure
2011
238
site/software ©
exaly
; All materials licenced under
CC by-SA
.